Chai Discovery, an artificial intelligence drug-discovery company backed by Sam Altman’s OpenAI, has secured $130 million funding in a bid to revolutionize AI drug design. According ...

After reportedly flirting with going public for years, the artificial intelligence-powered drug developer Insilico Medicine ...

Experts have been raising concerns about “AI washing.” One of these experts, futurist Bernard Marr, has said that AI washing “involves exaggerating the capabilities of a product or service that is ...

The artificial intelligence-powered drug designer Atomwise has raised $123 million in venture capital funding, to both scale up its platform and its partnerships with large biopharma companies, and to ...

AI in drug discovery is evolving fast. Join the experts behind today’s real progress as they share what works, what doesn’t ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes as tech ...

Conversations on drug forums can get nerdy. People looking to push the barriers of their mental and bodily experience tend to know a lot about the vagaries of the law, organic chemistry, metaphysics ...

Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 9, 2023) - PurMinds NeuroPharma ("PurMinds™" or the "Company"), a clinical-stage neuroscience company focused on neurological and ...

When it comes to developing a new medicine, designing the active compound is only half the battle. “Many potential therapeutic compounds are hydrophobic—oily—so they’re not very stable in aqueous ...

SCIENTIFIC PAPERS are normally models of discreet understatement. They are also (or are at least supposed to be) loaded with the information needed for others to replicate their findings. Not this one ...